Further verification focused on ROCK1, and immunofluorescence staining confirmed enhanced expression of RhoA and ROCK1 in prostate sections from BPH patients with positive signals primarily distributed around the glands (Fig. 4G-J). Here, RHOA is linked to benign prostatic hyperplasia.